InvestorsHub Logo
icon url

RJFL

12/02/15 5:27 PM

#131976 RE: Ernesto #131971

I think it's crazy to say the price per share impact is backed in considering much more explicit information will be released with the full reports. I think you minimize the potential for a very favorable PPS response from the full report for the first drug to clear the toxicity hurdle and which has been shown to induce activation of p53. Dana Farber BI are not mom and pop cancer treatment centers. My opinion is we will see a very good pop on the release of the full reports. The point is I state it's my opinion, I don't throw out stuff saying they are facts.